Kennedy, M J <br/><br/>
Metastatic breast cancer.  [electronic resource] 

 -  Current opinion in oncology  Nov 1996 
 - 485-90 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1040-8746 
<br/><br/><label>Standard No.: </label>10.1097/00001622-199611000-00007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenine<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Neoplasm--therapeutic use<br/>Antimetabolites, Antineoplastic--therapeutic use<br/>Antineoplastic Agents, Phytogenic--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Aromatase Inhibitors<br/>Bone Neoplasms--drug therapy<br/>Breast Neoplasms--drug therapy<br/>Clinical Trials as Topic<br/>Clinical Trials, Phase II as Topic<br/>Deoxycytidine--analogs & derivatives<br/>Diphosphonates--therapeutic use<br/>Docetaxel<br/>Doxorubicin--administration & dosage<br/>Enzyme Inhibitors--therapeutic use<br/>Female<br/>Humans<br/>Imides--therapeutic use<br/>Intercalating Agents--therapeutic use<br/>Isoquinolines--therapeutic use<br/>Naphthalimides<br/>Neoplasm Metastasis<br/>Neoplasm Proteins--antagonists & inhibitors<br/>Organophosphonates<br/>Paclitaxel--administration & dosage<br/>Randomized Controlled Trials as Topic<br/>Salvage Therapy<br/>Taxoids<br/>Topoisomerase II Inhibitors<br/>Treatment Outcome<br/>Gemcitabine